Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
May 1976

Hazards of Heparin Therapy

Arch Surg. 1976;111(5):614-615. doi:10.1001/archsurg.1976.01360230114031

To the Editor.—Ariyan and Stansel's recent observation on delayed bleeding after vascular surgery with the use of heparin sodium (Arch Surg 111:120-121, 1976) is not only of considerable practical, clinical significance, but also tends to confirm a basic theoretical concept, namely, that fibrin deposition is not a static but a dynamic process. The explanation for this concept, which also explains how heparin therapy promotes the "spontaneous" disappearance of thrombi, is simple. Thrombin clotting activity is readily inhibited by heparin; thrombin esterase activity is not.1 Thrombin esterase activates plasminogen.

It should be recalled that thrombin and plasminogen are integral components of a clot; in fact, both are firmly bound to fibrin. Treatment with heparin, leaving thrombin esterase activity unaffected, is expected to result in a fibrin-associated localized fibrinolysis in thrombi and in fibrin deposited at the site of a vascular anastomosis. However, it interferes with the thrombin clotting activity, thus

First Page Preview View Large
First page PDF preview
First page PDF preview